Effective use of rituximab for acquired amegakaryocytic thrombocytopenia.
Deeren
Dries
D
Dorpe
Jo Van
JV
D000230:Adenocarcinoma / Q000150:complications; D000369:Aged, 80 and over; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008533:Megakaryocytes / Q000473:pathology*; D000069283:Rituximab; D013274:Stomach Neoplasms / Q000150:complications; D013921:Thrombocytopenia / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome
D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab